INGERSOLL-RAND ($IR) posted quarterly earnings results for Q1 2026 on Tuesday, April 28th. The company reported earnings of $0.77 per share, beating estimates of $0.76 by $0.01. The company also reported revenue of $1,847,200,000, missing estimates of $1,889,314,765 by $-42,114,765.
Stock price change since market close: -2.55%
You can see Quiver Quantitative's $IR stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
INGERSOLL-RAND Insider Trading Activity
INGERSOLL-RAND insiders have traded $IR stock on the open market 21 times in the past 6 months. Of those trades, 0 have been purchases and 21 have been sales.
Here’s a breakdown of recent trading of $IR stock by insiders over the last 6 months:
- VICENTE REYNAL (See Remarks) has made 0 purchases and 13 sales selling 533,228 shares for an estimated $49,677,487.
- VIKRAM KINI (Senior Vice President and CFO) sold 28,367 shares for an estimated $2,737,415
- MICHAEL J SCHESKE (VP, Chief Accounting Officer) has made 0 purchases and 3 sales selling 20,599 shares for an estimated $1,986,647.
- ELIZABETH MELOY HEPDING (See Remarks) sold 18,246 shares for an estimated $1,771,869
- ANDREW R SCHIESL (See Remarks) sold 18,000 shares for an estimated $1,764,000
- KATHLEEN M. KEENE (See Remarks) sold 12,000 shares for an estimated $1,193,520
- JOHN HUMPHREY sold 4,300 shares for an estimated $412,370
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
INGERSOLL-RAND Hedge Fund Activity
We have seen 358 institutional investors add shares of INGERSOLL-RAND stock to their portfolio, and 415 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 15,244,412 shares (-73.2%) from their portfolio in Q4 2025, for an estimated $1,207,662,318
- PRICE T ROWE ASSOCIATES INC /MD/ removed 5,197,822 shares (-37.4%) from their portfolio in Q4 2025, for an estimated $411,771,458
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 3,196,609 shares (-17.4%) from their portfolio in Q4 2025, for an estimated $253,235,364
- WELLINGTON MANAGEMENT GROUP LLP removed 3,008,034 shares (-62.2%) from their portfolio in Q4 2025, for an estimated $238,296,453
- CAPITAL WORLD INVESTORS removed 2,373,436 shares (-7.5%) from their portfolio in Q4 2025, for an estimated $188,023,599
- CAPITAL INTERNATIONAL INVESTORS added 2,351,781 shares (+4.7%) to their portfolio in Q4 2025, for an estimated $186,308,090
- LAZARD ASSET MANAGEMENT LLC added 1,884,586 shares (+inf%) to their portfolio in Q4 2025, for an estimated $149,296,902
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
INGERSOLL-RAND Analyst Ratings
Wall Street analysts have issued reports on $IR in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 01/12/2026
- Wells Fargo issued a "Overweight" rating on 01/07/2026
- Baird issued a "Outperform" rating on 11/03/2025
To track analyst ratings and price targets for INGERSOLL-RAND, check out Quiver Quantitative's $IR forecast page.
INGERSOLL-RAND Price Targets
Multiple analysts have issued price targets for $IR recently. We have seen 6 analysts offer price targets for $IR in the last 6 months, with a median target of $97.0.
Here are some recent targets:
- Nathan Jones from Stifel set a target price of $90.0 on 04/14/2026
- Andrew Kaplowitz from Citigroup set a target price of $113.0 on 04/13/2026
- Julian Mitchell from Barclays set a target price of $100.0 on 04/01/2026
- Joseph O'Dea from Wells Fargo set a target price of $90.0 on 04/01/2026
- David Raso from Evercore ISI Group set a target price of $94.0 on 02/23/2026
- Michael Halloran from Baird set a target price of $100.0 on 11/03/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
